Future studies should also aim to examine the generalizability of our findings (e.g., CD8+ T cell repertoire; other autoimmune diseases; pre-T1D; rate of progression; age of T1D onset), as well as gain a better understanding of the molecular mechanisms of abnormal TCR rearrangement. The gene discussed is CD8A; the disease is type 1 diabetes mellitus.